Our team is working passionately toward improving public health.

RAJEEV VENKAYYA, MD

President, Takeda Vaccine Business

Rajeev is President of the Takeda Vaccine Business. He joined Takeda in 2012 to launch the global vaccine business. He was previously Director of Vaccine Delivery in the Global Health Program at the Bill & Melinda Gates Foundation, and prior to that, Special Assistant to the President for Biodefense at the White House.

JOHN BOSLEGO, MD

Head of Development

John is Head of Development for the Takeda Vaccine Business. His prior experience includes Director of the Vaccine Development Global Program at PATH, Executive Director at Merck Research Laboratories and the Deputy Director at the Walter Reed Army Institute of Research in Washington, DC.

Rahul Singhvi, ScD, MBA

Chief Operating Officer and Head of Vaccine Operations

Rahul is Chief Operating Officer, leads the Vaccine Operations team, and is responsible for the global supply of vaccines at Takeda. He has a wealth of experience in vaccine development and manufacturing. Before joining Takeda, Rahul was President and CEO of Novavax.

TAKAYUKI NAKANO, PhD, MBA

Head of Business Planning, Japan Business Coordinator

Takayuki is Head of Business Planning and Japan Business Coordinator. As Head of Business Planning, Takayuki is responsible for business strategy planning, vaccine portfolio management and ensuring organizational governance. As Japan Business Coordinator, he works on strengthening coordination between Japan-based functions and their global counterparts. Takayuki joined Takeda in 2000 and worked in Takeda’s R&D organization prior to joining the Vaccine business.

Gary Dubin, MD

Head of Global Medical Office

Gary is the Senior Vice President, Head of the Global Medical Office, and leads the Takeda Vaccine Business Medical Affairs and Policy team. He is responsible for vaccines safety and medical governance. He spent the previous 20 years at GSK Vaccines.

Hansi Dean, PhD

Head of Discovery Research

Hansi is Head of Discovery Research for the Takeda Vaccine Business. Hansi joined Takeda in 2014. She was previously Director of New Alliances at the International AIDS Vaccine Initiative, and prior to that a Director at PowderJect and Group Leader for Viral Vaccine Development at Schering Plough.

Elena Cant, BS, MBA

Head of Commercial

Elena is the Takeda Vaccine Business' Head of Global Commercial, and was previously Head of Global Business Operations for the Takeda Vaccine Business, which she joined in 2012. Prior to joining Takeda, Elena worked at McKinsey & Company, Hospira, and at Mead Johnson Nutrition.

Tetsu Inada, BS, MBA

Head of Finance

Tetsu has been Head of Finance for the Takeda Vaccine Business since 2013. Prior to that Tetsu was at Millennium Pharmaceuticals since 2001, and he joined Takeda through the acquisition of Millennium in 2008.